Home
About
Overview
Sharing Data
ORCID
Help
History (63)
Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells.
Simulations of enhancer evolution provide mechanistic insights into gene regulation.
Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses.
Cross-reactivity influences changes in human influenza A virus and Epstein Barr virus specific CD8 memory T cell receptor alpha and beta repertoires between young and old.
Improving Viral Protease Inhibitors to Counter Drug Resistance.
See All 63 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Improving Viral Protease Inhibitors to Counter Drug Resistance.
Kurt Yilmaz N, Swanstrom R, Schiffer CA. Improving Viral Protease Inhibitors to Counter Drug Resistance. Trends Microbiol. 2016 07; 24(7):547-557.
View in:
PubMed
subject areas
Drug Design
Drug Resistance, Viral
Hepatitis C
HIV Infections
HIV Protease
Humans
Protease Inhibitors
authors with profiles
Celia A Schiffer PhD
Nese Kurt Yilmaz PhD